Sensitive Detection and Quantification of Leukemia BiomarkersIntroducing ipsogen oncohematology solutions from QIQGEN to provide sensitive and reliable detection and quantitative, qualitative or semi-quantitative analysis of a range of blood cancer biomarkers, enabling you to unlock new insights.
Our Leukemia test menu includes:
Trusted Portfolio of Solid Tumor AssaysIntroducing therascreen from QIAGEN to provide a trusted portfolio of solid tumor assays, enabling rapid and sensitive detection for your oncogene analyses. therscreen Solid Tumor portfolio includes assays for both FFPE and liquid biopsy analysis.
Our Sold Tumor test menu includes:
EGFR, EGFR Plasma, FGFR, PITX2, PIK3CA & KRAS
Generating Clinically Actionable Results That Optimize TreatmentsIntroducing invivoscribe Precision Diagnostics solutions - diagnostic products and reagents for leukemias and lymphomas to generate meaningful results allowing healthcare providers to confirm or modify treatment for each patient.
A full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, RUO assays, and analyte-specific reagents (ASRs), and DNA & RNA controls.
Our test menu includes:
Introducing G2M in vitro diagnostic tests for qualitative detection of oncogene mutations including major genes and gene fusions involved in protein production involved in cell growth and cell survival.
A broad range of CE-IVD approved RT-PCR IVD kits with high sensitivity and specificity, enabling accurate identification of oncology diseases. These RT-PCR kits are extensively compatible with commonly available real time PCR Instruments and hold no cross-reactivity with other pathogens.
Our test menu includes:
Salah Alden Road | Al Zahra District
Riyadh | Kingdom of Saudi Arabia
60001 Riyadh 11545
